India's Dr. Reddy's gets FDA nod for simvastatin

MUMBAI, Aug 22 (Reuters) - Indian drug maker Dr. Reddy's Laboratories Ltd. (REDY.BO) (RDY.N) has received approval from the U.S. Food and Drug Administration for cholesterol-lowering simvastatin tablets, the regulator's Web site showed.

Dr. Reddy's, which already makes the drug -- the generic equivalent of Merck & Co Inc's (MRK.N) Zocor -- in multiple strengths, has received FDA approval for 5 mg tablets.

((Reporting by Rina Chandran, editing by Ranjit Gangadharan; Reuters Messaging: rina.chandran.reuters.com@reuters.net; +91 22 6636 9251)) Keywords: REDDYS APPROVAL/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nBOM297062